Novel insights into the synergistic interaction of Bortezomib and TRAIL: tBid provides the link
- Sprache
-
Englisch
- Identifier
-
1093586737
Thema
Krebs; Onkologie
Beteiligte Personen und Organisationen
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:53 MEZ
Ähnliche Objekte (12)
ABT-737 promotes tBid mitochondrial accumulation to enhance TRAIL-induced apoptosis in glioblastoma cells
Inhibitor of apoptosis proteins in pediatric leukemia : molecular pathways and novel approaches to therapy
Targeting apoptosis signaling in pancreatic cancer
Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma
Evasion of apoptosis as a cellular stress response in cancer
Betulinic acid for cancer treatment and prevention
Regulation of cell death in cancer - possible implications for immunotherapy
Cell death pathways as therapeutic targets in rhabdomyosarcoma
Alternative cell death pathways and cell metabolism
How to target apoptosis signaling pathways for the treatment of pediatric cancers
Shifting the balance of mitochondrial apoptosis: therapeutic perspectives
Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implications
ABT-737 promotes tBid mitochondrial accumulation to enhance TRAIL-induced apoptosis in glioblastoma cells
Inhibitor of apoptosis proteins in pediatric leukemia : molecular pathways and novel approaches to therapy
Targeting apoptosis signaling in pancreatic cancer
Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma
Evasion of apoptosis as a cellular stress response in cancer
Betulinic acid for cancer treatment and prevention
Regulation of cell death in cancer - possible implications for immunotherapy
Cell death pathways as therapeutic targets in rhabdomyosarcoma
Alternative cell death pathways and cell metabolism
How to target apoptosis signaling pathways for the treatment of pediatric cancers
Shifting the balance of mitochondrial apoptosis: therapeutic perspectives
Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implications
ABT-737 promotes tBid mitochondrial accumulation to enhance TRAIL-induced apoptosis in glioblastoma cells
Inhibitor of apoptosis proteins in pediatric leukemia : molecular pathways and novel approaches to therapy
Targeting apoptosis signaling in pancreatic cancer
Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma
Evasion of apoptosis as a cellular stress response in cancer
Betulinic acid for cancer treatment and prevention
Regulation of cell death in cancer - possible implications for immunotherapy
Cell death pathways as therapeutic targets in rhabdomyosarcoma
Alternative cell death pathways and cell metabolism
How to target apoptosis signaling pathways for the treatment of pediatric cancers
Shifting the balance of mitochondrial apoptosis: therapeutic perspectives